2023 Prepped and Primed: Medlab (ASX:MDC) with CEO, Dr Sean Hall
Stockhead’s Prepped and Primed video series is a summary of development plans from company leaders, who share what investors can expect to see in the year ahead.
In this instalment Dr Sean Hall, CEO and executive director at Medlab (ASX:MDC), shares his outlook for 2023.
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®.
To hear about the company’s upcoming 2023, click above.
Related Topics
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.